Mode
Text Size
Log in / Sign up
Phase 4 N=38 Randomized Double-blind Treatment

Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty - A Randomized Clinical Trial

Total Knee Replacement

Enrolled (actual)
38
Serious AEs
0.0%
Results posted
May 2012
Primary outcome: Primary: Change in Western Ontario MacMaster (WOMAC) Osteoarthritis Index Pain Score From Preoperative to 5 Years Postoperative — 34.7; 39.2 units on a scale — p=0.59

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Patellar Replacement Prosthesis (Device); Profix TKR with Patellar Retention (Device)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
University of Alberta
Primary completion
Jun 2004

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Western Ontario MacMaster (WOMAC) Osteoarthritis Index Pain Score From Preoperative to 5 Years Postoperative
34.7; 39.2 0.59
PRIMARY
Change in WOMAC Osteoarthritis Index Function Score From Preoperative to 5 Years Postoperative
21.8; 27.5 0.39
PRIMARY
Change in WOMAC Osteoarthritis Index Stiffness Score From Preoperative to 5 Years Postoperative
38.2; 29.2 0.43
SECONDARY
Change in WOMAC Osteoarthritis Index Pain Score From Preoperative to 1 Year Postoperative
32.9; 34.3 0.83
SECONDARY
Change in WOMAC Osteoarthritis Index Function Score From Preoperative to 1-year Postoperative
24.1; 19.5
SECONDARY
Change in WOMAC Osteoarthritis Index Stiffness Score From Preoperative to 1 Year Postoperative
24.4; 8.3 0.10
SECONDARY
Change in WOMAC Osteoarthritis Index Pain Score From 5 Years Postoperative to 10 Years Postoperative
12.7; 10.0 0.71
SECONDARY
Change in WOMAC Osteoarthritis Index Function Score From 5 Years Postoperative to 10 Years Postoperative
14.2; 14.4 0.98
SECONDARY
Change in WOMAC Osteoarthritis Index Stiffness Score From 5 Years Postoperative to 10 Years Postoperative
3.4; 15.0 0.35
SECONDARY
Number of Revision Surgeries
3; 1 0.31

Summary

Background: Despite the excellent results of total knee replacement, also known as total knee arthroplasty (TKA) there is persistent controversy over whether or not to replace the surface of the kneecap. Anterior knee pain, which occurs with variable and unpredictable frequency, continues to be a problem in a subset of TKA patients. Some clinicians replace the surface of all kneecaps during TKA to avoid repeat surgery, which occurs in approximately 10% of cases. However, others cite the complications attributed to replacing the surface of kneecap as reasons to avoid this procedure. This study prospectively randomized patients receiving TKA into two groups, those receiving replacement of the kneecap surface and those left without replacement of the kneecap surface to determine clinical outcomes and revisions over the first 5-10 postoperative years. Objectives: The primary objective of this work was to compare pain, stiffness and function between groups at five years postoperatively. Secondarily, we compared pain, stiffness and function at one and 10 years postoperatively. Finally, we examined the number of reoperations following TKR over 10 years in the 2 groups of subjects. The investigators hypothesized that there would be no difference between the two groups of subjects in the measured outcomes. Methods: Patients receiving TKA were prospectively enrolled before surgery and randomized intraoperatively to either receive a replacement of the kneecap surface or have no kneecap intervention. The Smith and Nephew Profix TKA system was implanted in all cases; the post-operative regimen was standardized. Subjects were assessed pre-operatively and at 1 and 5 years postoperatively for pain, function, and stiffness using a disease-specific (Western Ontario and MacMaster Osteoarthritis Index [WOMAC]) and generic health status (Short Form 36 [SF-36]) questionnaire. At the end of the five year follow-up, the study was extended to a 10-year followup and the same outcomes were assessed. The revision rate was also compared between the two groups at the end of the 10-year follow-up.

Eligibility Criteria

Inclusion Criteria

  • scheduled for primary TKA to treat non-inflammatory arthritis
  • age 40- 75 years of age

Exclusion Criteria

  • history of knee sepsis
  • previous patellectomy
  • previous high tibial osteotomy
  • knee flexion contracture of >20 degrees
  • varus or valgus deformity of > 20 degrees
  • < 90 degrees of knee flexion
  • tibial or femoral bone deficiency requiring augmentation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01500252). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search